# AdaptiveFlow releases open-source platform for billion-molecule drug screens

_Published Tuesday, September 1, 2026 at 6:06 PM EDT · Science · Latest · Tier 2 — Notable_

![AdaptiveFlow releases open-source platform for billion-molecule drug screens — Primary](https://scx2.b-cdn.net/gfx/news/hires/2026/ai-informed-adaptivefl-1.jpg)

Researchers from St. Jude Children's Research Hospital, the University of Pavia, Dana-Farber Cancer Institute and Harvard Medical School announced AdaptiveFlow, an open-source platform for virtual drug screening. The team reported linear scaling to 5.6 million virtual CPUs and a 1,000-fold reduction in computational costs over existing methods. In proof-of-concept work, the platform identified inhibitors for PARP1 and FSP1; the findings were published in Nature Biotechnology.

## Sources

- [Phys.org](https://phys.org/news/2026-09-ai-adaptiveflow-redefines-large-scale.html)

---
Canonical: https://techandbusiness.org/newswire/cmnDKvCXZl1PWm83ROGGOB
Published: 2026-09-01T22:06:57.871Z
Story chronology: 2026-09-01T21:00:07.000Z
Retrieved: 2026-10-17T04:26:27.747Z
Publisher: Tech & Business (techandbusiness.org)